Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy
{{output}}
The tumor microenvironment (TME) is a heterogeneous ecosystem containing cancer cells, immune cells, stromal cells, cytokines, and chemokines which together govern tumor progression and response to immunotherapies. Methyltransferase-like 3 (METTL3), a core cat... ...
